代表文章:
(1) Ying L, Wang Q. Microfluidic chip-based technologies: emerging platforms for cancer diagnosis. BMC Biotechnol. 2013;13:76. (2) Ying L, Zhu ZW, Xu ZY, He TR, Li EC, Guo Z, Liu F, Jiang CM, Wang Q. Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung cancer A549 cells by up-regulating the PI3K/Akt and GRP78 signaling on a microfluidic platform. PLoS One. 2015;10(6):e0129593.